Counteracting the effects of TNF receptor‐1 has therapeutic potential in Alzheimer's disease
Sophie Steeland(Ghent University), Roosmarijn E. Vandenbroucke(Ghent University), Elien Van Wonterghem(Ghent University), Marjana Brkić(Ghent University), Nina Gorlé(Ghent University), Conrad E. Johanson(Texas Tech University), Riet De Rycke(Vlaams Instituut voor Biotechnologie), Caroline Van Cauwenberghe(University of Antwerp), Griet Van Imschoot(Ghent University), Charysse Vandendriessche(Ghent University), Claude Libert(Ghent University), Edward G. Stopa, Saskia Lippens(Ghent University), Anneke Kremer(Ghent University), Sriram Balusu(Allen Institute for Brain Science)
Cited by 119
Related Papers
Is there new hope for therapeutic matrix metalloproteinase inhibition?
|Nature Reviews Drug Discovery|2014|814
A General Introduction to Glucocorticoid Biology
|Frontiers in Immunology|2019|588
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
|Molecular Psychiatry|2013|440
Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check
|Journal of Clinical Oncology|2007|414